EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single-cell sequencing reveals novel proliferative cell type: a key player in renal cell carcinoma prognosis and therapeutic response

Bicheng Ye, Hongsheng Ji, Meng Zhu, Anbang Wang, Jingsong Tang, Yong Liang, Qing Zhang

Clinical and Experimental Medicine · 2024

DOI: 10.1007/s10238-024-01424-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Medicine, 2024. Verfasst von Bicheng Ye und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Yangzhou Polytechnic College, Yangzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Single-Cell Analysis, Kidney Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic Research On Health Foundation of Huai'an, Basic Research On Health Foundation of Huai′an.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal cell carcinoma (RCC) is characterized by a variety of subtypes, each defined by unique genetic and morphological features. This study utilizes single-cell RNA sequencing to explore the molecular heterogeneity of RCC. A highly proliferative cell subset, termed as “Prol,” was discovered within RCC tumors, and its increased presence was linked to poorer patient outcomes. An artificial intelligence network, encompassing traditional regression, machine learning, and deep learning algorithms, was employed to develop a Prol signature capable of predicting prognosis. The signature demonstrated superior performance in predicting RCC prognosis compared to other signatures and exhibited pan-cancer prognostic capabilities. RCC patients with high Prol signature scores exhibited resistance to targeted therapies and immunotherapies. Furthermore, the key gene CEP55 from the Prol signature was validated by both proteinomics and quantitative real time polymerase chain reaction. Our findings may provide new insights into the molecular and cellular mechanisms of RCC and facilitate the development of novel biomarkers and therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellSingle-Cell AnalysisKidney NeoplasmsHumansPrognosisCell ProliferationFemaleMaleSequence Analysis, RNABiomarkers, TumorMiddle AgedGene Expression Profiling

Stichwörter der Autor:innen

Artificial intelligenceImmunotherapyPrognosisRenal cell carcinomaSingle-cell RNA sequencing

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • School of Clinical Medicine, Yangzhou Polytechnic College, Yangzhou, China.
  • Department of Urology, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
  • Department of Urology, Lianshui People's Hospital of Kangda College Affiliated to Nanjing Medical University, Huai'an, China.
  • Department of Geriatrics, The Affiliated Huaian Hospital of Xuzhou Medical University, Huaian Second People's Hospital, Huaian, China.
  • Department of General Surgery, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, China. 55460830@qq.com.
  • Department of Medical Laboratory, Huai'an Second People's Hospital Affiliated to Xuzhou Medical Universit, Huaian, China. harcyyly@163.com.

Förderung

  • Basic Research On Health Foundation of Huai'an
  • Basic Research On Health Foundation of Huai′an

Zitieren

APA

Ye, B., Ji, H., Zhu, M., Wang, A., Tang, J., Liang, Y., & Zhang, Q. (2024). Single-cell sequencing reveals novel proliferative cell type: a key player in renal cell carcinoma prognosis and therapeutic response. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-024-01424-x

Vancouver

Ye B, Ji H, Zhu M, Wang A, Tang J, Liang Y, et al. Single-cell sequencing reveals novel proliferative cell type: a key player in renal cell carcinoma prognosis and therapeutic response. Clinical and Experimental Medicine. 2024. doi:10.1007/s10238-024-01424-x

BibTeX
@article{Ye2024,
  author = {Ye, Bicheng and Ji, Hongsheng and Zhu, Meng and Wang, Anbang and Tang, Jingsong and Liang, Yong and Zhang, Qing},
  title = {Single-cell sequencing reveals novel proliferative cell type: a key player in renal cell carcinoma prognosis and therapeutic response},
  journal = {Clinical and Experimental Medicine},
  year = {2024},
  doi = {10.1007/s10238-024-01424-x}
}
Kostenlos starten →